WO1999060948A3 - Principe permettant de traiter des maladies oculaires - Google Patents

Principe permettant de traiter des maladies oculaires Download PDF

Info

Publication number
WO1999060948A3
WO1999060948A3 PCT/RU1999/000172 RU9900172W WO9960948A3 WO 1999060948 A3 WO1999060948 A3 WO 1999060948A3 RU 9900172 W RU9900172 W RU 9900172W WO 9960948 A3 WO9960948 A3 WO 9960948A3
Authority
WO
WIPO (PCT)
Prior art keywords
medium
polyethyleneglycol
eye diseases
treating eye
active substance
Prior art date
Application number
PCT/RU1999/000172
Other languages
English (en)
French (fr)
Other versions
WO1999060948A2 (fr
Inventor
Emiliya Mikhailovna Mironova
Evgeny Vasilievich Grishin
Original Assignee
Emiliya Mikhailovna Mironova
Evgeny Vasilievich Grishin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emiliya Mikhailovna Mironova, Evgeny Vasilievich Grishin filed Critical Emiliya Mikhailovna Mironova
Priority to AU41750/99A priority Critical patent/AU4175099A/en
Publication of WO1999060948A2 publication Critical patent/WO1999060948A2/ru
Publication of WO1999060948A3 publication Critical patent/WO1999060948A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PCT/RU1999/000172 1998-05-27 1999-05-25 Principe permettant de traiter des maladies oculaires WO1999060948A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU41750/99A AU4175099A (en) 1998-05-27 1999-05-25 Medium for treating eye diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU98110113A RU2125427C1 (ru) 1998-05-27 1998-05-27 Средство для лечения глазных заболеваний - оковидит
RU98110113 1998-05-27

Publications (2)

Publication Number Publication Date
WO1999060948A2 WO1999060948A2 (fr) 1999-12-02
WO1999060948A3 true WO1999060948A3 (fr) 2000-02-10

Family

ID=20206511

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1999/000172 WO1999060948A2 (fr) 1998-05-27 1999-05-25 Principe permettant de traiter des maladies oculaires

Country Status (3)

Country Link
AU (1) AU4175099A (ru)
RU (1) RU2125427C1 (ru)
WO (1) WO1999060948A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4629578B2 (ja) * 2003-01-22 2011-02-09 ニチバン株式会社 眼疾患治療用経皮吸収型製剤
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
JP2010534201A (ja) * 2007-07-20 2010-11-04 アルコン，インコーポレイテッド 受容体チロシンキナーゼ阻害（ＲＴＫｉ）化合物の目への送達のための医薬製剤

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2242991A1 (en) * 1973-09-12 1975-04-04 Prat Andre Liq. marine algal extracts - used in pharmacological, therapeutic or cosmetic compsns
FR2513121A1 (fr) * 1981-09-23 1983-03-25 Goemar Sa Nouveaux medicaments, produits cosmetiques et produits dietetiques a base d'extraits d'algues, et formulations correspondantes
RU2005485C1 (ru) * 1991-04-12 1994-01-15 Станислав Григорьевич Батраков Способ получения средства для лечения заболеваний кожи у животных
RU2019186C1 (ru) * 1991-02-28 1994-09-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи Способ ингибиции вич-инфекции
RU2062079C1 (ru) * 1993-08-25 1996-06-20 Уфимский научно-исследовательский институт глазных болезней Глазные капли
RU2092138C1 (ru) * 1990-05-29 1997-10-10 Окьюлар Рисерч оф Бостон, Инк. Композиция для получения пленки на поверхности глаза и способ получения пленки на поверхности глаза

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2242991A1 (en) * 1973-09-12 1975-04-04 Prat Andre Liq. marine algal extracts - used in pharmacological, therapeutic or cosmetic compsns
FR2513121A1 (fr) * 1981-09-23 1983-03-25 Goemar Sa Nouveaux medicaments, produits cosmetiques et produits dietetiques a base d'extraits d'algues, et formulations correspondantes
RU2092138C1 (ru) * 1990-05-29 1997-10-10 Окьюлар Рисерч оф Бостон, Инк. Композиция для получения пленки на поверхности глаза и способ получения пленки на поверхности глаза
RU2019186C1 (ru) * 1991-02-28 1994-09-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи Способ ингибиции вич-инфекции
RU2005485C1 (ru) * 1991-04-12 1994-01-15 Станислав Григорьевич Батраков Способ получения средства для лечения заболеваний кожи у животных
RU2062079C1 (ru) * 1993-08-25 1996-06-20 Уфимский научно-исследовательский институт глазных болезней Глазные капли

Also Published As

Publication number Publication date
WO1999060948A2 (fr) 1999-12-02
RU2125427C1 (ru) 1999-01-27
AU4175099A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
DE69007626T2 (de) Verwendung von algenextrakten zur herstellung von pharmazeutika, kosmetika, nahrungsmitteln oder zum landwirtschaftlichen gebrauch.
WO1996029867A3 (en) Fast acting and persistent topical antiseptic
DE69427814T2 (de) Kupplungsprodukt zwischen einer aminosaeure und histamin
CA2209167A1 (en) Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
AU9125798A (en) Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
IE811654L (en) Ophthalmic composition
DE69425153T2 (de) Pseudodipeptid-produkte, die eine imidazol-gruppe enthalten und ihre anwendungen
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
US5268176A (en) Method and compositions for the non-invasive treatment of telangiectasia
JPH0892057A (ja) コーヒーノキ種子抽出物配合化粧料
WO1996005797A3 (fr) Agent a application externe aux proprietes nutritives et protectrices
CA1172571A (en) Extract of stalk of sunflower
CA2180846A1 (en) Method of treating disorders of the eye
EP0678013B1 (en) Compositions for treatment of the hair
JP2005530766A (ja) ４−ヒドロキシ−５−メトキシ−４−［２−メチル−３−（３−メチル−２−ブテニル）−２−オキシラニル］−１−オキサスピロ［２，５］オクタン−６−オンを含有する脂漏症治療用医薬組成物
WO1999060948A3 (fr) Principe permettant de traiter des maladies oculaires
JPS5976007A (ja) 化粧料
JPS62501072A (ja) ス−パ−オキシドジスムタ−ゼを含有する配合物を使用して皮膚の刺激を予防または軽減する方法
WO2002062952A3 (en) Non-cytotoxic pap mutants
DE69809080T2 (de) Kombination aus phenolderivaten und einem extrakt von iridaceen zur depigmentierung der haut oder ihrer anhangsgebilde und diese kombination enthaltende zusammensetzung
WO1996032134A3 (de) Konjugat aus einem wirkstoff, einem polyether und ggf. einem nicht als körperfremd angesehenen, nativen protein
AU1829195A (en) Energy formulation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase